Not the Lancet, not NEJM, not JAMA, so as I suggested might happen we eventually diverted after a long wait for a top-tier journal to a lower-tier journal.
At least it’s out there though. 2 years and the impact is going to be less for shareholders than we got just on hype running up to SNO 2020 but at least the conversation can move on.